Identification of Novel Tumor-Associated Cell Surface Sialoglycoproteins in Human Glioblastoma Tumors Using Quantitative Proteomics

Construction of an Immunotoxin, D2C7-(scdsFv)-PE38KDEL, Targeting EGFRwt and EGFRvIII for Brain Tumor Therapy

(2013) V. Chandramohan et al.   CLINICAL CANCER RESEARCH

Affinity-matured recombinant immunotoxin targeting gangliosides 3′-isoLM1 and 3′,6'-isoLD1 on malignant gliomas

(2013) Hailan Piao et al.   mAbs

Transcriptional Differences between Normal and Glioma-Derived Glial Progenitor Cells Identify a Core Set of Dysregulated Genes

(2013) Romane M. Auvergne et al.   Cell Reports

Toxin-Based Targeted Therapy for Malignant Brain Tumors

(2012) Vidyalakshmi Chandramohan et al.   Clinical & Developmental Immunology

Comparative genomic and proteomic analysis of high grade glioma primary cultures and matched tumor in situ

(2012) R. Howley et al.   EXPERIMENTAL CELL RESEARCH

Recombinant anti-podoplanin (NZ-1) immunotoxin for the treatment of malignant brain tumors

(2012) Vidyalakshmi Chandramohan et al.   INTERNATIONAL JOURNAL OF CANCER

CD24 Expression as a Marker for Predicting Clinical Outcome in Human Gliomas

(2012) Jianping Deng et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

LC-MS/MS Analysis of Differentially Expressed Glioblastoma Membrane Proteome Reveals Altered Calcium Signaling and Other Protein Groups of Regulatory Functions

(2012) Ravindra Varma Polisetty et al.   MOLECULAR & CELLULAR PROTEOMICS

Current Strategies for Identification of Glioma Stem Cells: Adequate or Unsatisfactory?

(2012) Paola Brescia et al.   Journal of Oncology

From Mechanism to Mouse: A Tale of Two Bioorthogonal Reactions

(2011) Ellen M. Sletten et al.   ACCOUNTS OF CHEMICAL RESEARCH

Evaluation of a bispecific biological drug designed to simultaneously target glioblastoma and its neovasculature in the brain

(2011) Seunguk Oh et al.   JOURNAL OF NEUROSURGERY

CD140a identifies a population of highly myelinogenic, migration-competent and efficiently engrafting human oligodendrocyte progenitor cells

(2011) Fraser J Sim et al.   NATURE BIOTECHNOLOGY

Proteomics of gliomas: Initial biomarker discovery and evolution of technology

(2011) J. Kalinina et al.   NEURO-ONCOLOGY

Dynamic association of tau with neuronal membranes is regulated by phosphorylation

(2011) Amy M. Pooler et al.   NEUROBIOLOGY OF AGING

Parkinson’s disease-associated mutations in α-synuclein and UCH-L1 inhibit the unconventional secretion of UCH-L1

(2011) Chiho Konya et al.   NEUROCHEMISTRY INTERNATIONAL

PI3K/Akt signaling requires spatial compartmentalization in plasma membrane microdomains

(2011) X. Gao et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Polysialic Acid Neural Cell Adhesion Molecule (PSA-NCAM) is an adverse prognosis factor in glioblastoma, and regulates olig2 expression in glioma cell lines

(2010) Marie-Claude Amoureux et al.   BMC CANCER

Glioma Pathophysiology: Insights Emerging from Proteomics

(2010) Ruth F. Deighton et al.   BRAIN PATHOLOGY

Precision Mapping of an In Vivo N-Glycoproteome Reveals Rigid Topological and Sequence Constraints

(2010) Dorota F. Zielinska et al.   CELL

Glioblastoma-derived spheroid cultures as an experimental model for analysis of EGFR anomalies

(2010) Monika Witusik-Perkowska et al.   JOURNAL OF NEURO-ONCOLOGY

A Phase II study of anti–epidermal growth factor receptor radioimmunotherapy in the treatment of glioblastoma multiforme

(2010) Linna Li et al.   JOURNAL OF NEUROSURGERY

Glycoproteomic Analysis of Glioblastoma Stem Cell Differentiation

(2010) Jintang He et al.   JOURNAL OF PROTEOME RESEARCH

Glioma proteomics: Status and perspectives

(2010) Simone P. Niclou et al.   Journal of Proteomics

Interstitial Infusion of Glioma-Targeted Recombinant Immunotoxin 8H9scFv-PE38

(2010) Neal Luther et al.   MOLECULAR CANCER THERAPEUTICS

Towards a knowledge-based Human Protein Atlas

(2010) Mathias Uhlen et al.   NATURE BIOTECHNOLOGY

Selective enrichment of sialic acid–containing glycopeptides using titanium dioxide chromatography with analysis by HILIC and mass spectrometry

(2010) Giuseppe Palmisano et al.   Nature Protocols

Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma

(2010) S. Kunwar et al.   NEURO-ONCOLOGY

Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics

(2010) M. Candolfi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Targeting integrins in malignant glioma

(2010) Ghazaleh Tabatabai et al.   Targeted Oncology

Clusterin in Stool: A New Biomarker for Colon Cancer Screening?

(2009) Sabina Pucci et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality

(2009) Ellen M. Sletten et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Molecularly targeted therapies for glioma

(2009) Ryuya Yamanaka et al.   ANNALS OF NEUROLOGY

Sample Type Bias in the Analysis of Cancer Genomes

(2009) D. A. Solomon et al.   CANCER RESEARCH

Antibody-Drug Conjugate Targets

(2009) B. Teicher   CURRENT CANCER DRUG TARGETS

The clusterin paradigm in prostate and breast carcinogenesis

(2009) Federica Rizzi et al.   ENDOCRINE-RELATED CANCER

Astrocytoma derived short-term cell cultures retain molecular signatures characteristic of the tumour in situ

(2009) Nicola E. Potter et al.   EXPERIMENTAL CELL RESEARCH

Glioblastoma multiforme: a review of where we have been and where we are going

(2009) Cory Adamson et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy

(2009) Thomas R Webb et al.   Expert Review of Anticancer Therapy

Recombinant single-chain variable fragment antibodies against extracellular epitopes of human multidrug resistance protein MRP3 for targeting malignant gliomas

(2009) Chien-Tsun Kuan et al.   INTERNATIONAL JOURNAL OF CANCER

Intracranial elimination of human glioblastoma brain tumors in nude rats using the bispecific ligand-directed toxin, DTEGF13 and convection enhanced delivery

(2009) Seunguk Oh et al.   JOURNAL OF NEURO-ONCOLOGY

Poor drug distribution as a possible explanation for the results of the PRECISE trial

(2009) John H. Sampson et al.   JOURNAL OF NEUROSURGERY

iTRAQ-based Proteomics Profiling Reveals Increased Metabolic Activity and Cellular Cross-talk in Angiogenic Compared with Invasive Glioblastoma Phenotype

(2009) Uros Rajcevic et al.   MOLECULAR & CELLULAR PROTEOMICS

Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins

(2009) Bernd Wollscheid et al.   NATURE BIOTECHNOLOGY

Enrichment of glycopeptides for glycan structure and attachment site identification

(2009) Jonas Nilsson et al.   NATURE METHODS

Fate determination of adult human glial progenitor cells

(2009) Fraser J. Sim et al.   Neuron Glia Biology

BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources

(2009) Chunlei Wu et al.   GENOME BIOLOGY

Cintredekin besudotox in treatment of malignant glioma

(2008) Melike Mut et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Assessment of lectin and HILIC based enrichment protocols for characterization of serum glycoproteins by mass spectrometry

(2008) Cosima D. Calvano et al.   Journal of Proteomics

Targeted proteomic strategy for clinical biomarker discovery

(2008) Ralph Schiess et al.   Molecular Oncology

Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors

(2008) John H. Sampson et al.   NEURO-ONCOLOGY

Human Protein Reference Database--2009 update

(2008) T. S. Keshava Prasad et al.   NUCLEIC ACIDS RESEARCH

Imaging the glycome

(2008) S. T. Laughlin et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Targeted Cancer Therapy: Conferring Specificity to Cytotoxic Drugs

(2007) Ravi V. J. Chari   ACCOUNTS OF CHEMICAL RESEARCH